PRDM9 and neurodevelopmental disorder: Therefore, gaining an in depth understanding of the molecular signatures and cellular phenotypes associated with the pathogenic mutations in H3K36 and H3K4 histone methyltransferases in the etiology of various neurodevelopmental disorders will be instrumental in the potential development of mechanistic based therapeutic strategies.